Invitrogen has launched of GIBCO OpTmizer T-cell Expansion SFM, a next-generation solution for culturing and expanding human T-cells that does not require the addition of serum to achieve optimal, cost-efficient results. OpTmizer SFM will enable scientists to advance their research on the central role that T-cells play in human immune response. Obtaining large amounts of viable cells for these studies is critical to this work, and led Invitrogen to specifically formulate OpTmizer SFM to enable superior cell growth and viability with consistent results. It achieves superior performance criteria for growth, viability and cell yield under serum-free conditions, compared to other commercial T-cell media. This is an improvement over other products on the market which are limited in their performance without the addition of human serum to feed the cells – a process that adds cost, complexity and contamination risk.
Polls
Loading ...